Ensuring Lifelong Care: Transition Pathways and Lessons from Pediatric-Onset Inborn Errors of Immunity

Needs Statement

The Immunology, Allergy, and Retrovirology Grand Rounds aims to address the needs of all participants — as learners and audience members and as teachers, speakers, and expert panelists — through a dynamic educational process that captures the evolving scope of these fields. The forum will explore published research results, new clinical evidence, expert recommendations, practical demonstrations of clinical competencies, and strategies for quality improvement. There is an overarching need for instruction in allergic-immune disorders and affected populations that bridges basic science and practical clinical applications from bench to bedside to the larger community for all who care for patients and their families. Embracing the spirit of graduate medical education, this forum will provide faculty development in educational methods, humanism, professionalism, and mentorship while supporting self-assessment, growth, and the enjoyment of life-long learning and teaching. Ultimately, the series aims to empower participants as learners-teachers; to integrate up-to-date, evidence-based recommendations into patient care; and to adapt their clinical practice in alignment with current best practices and standards while upholding professional development.

Educational Objectives

At the conclusion of the activity, the participants should be able to:

• Recognize key challenges and models in healthcare transition for patients with chronic diseases.
• Describe unique barriers and outcomes in transitioning individuals with inborn errors of immunity.
• Discuss strategies to build effective transition pathways and sustain lifelong immunology care.
• Examine ethical considerations in ensuring equitable and continuous care during healthcare transition.

Target Audience

Activity Evaluation

Evaluation by questionnaire will address program content, presentation, and possible bias.

Educational Methods

• Lectures
• Case Presentations
• Literature Review
• Panel Discussion
• Other

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of the participation in the activity.

This activity has been designated by Baylor College of Medicine for 1 credit of education in medical ethics and/or professional responsibility.

Social Work: The Baylor College of Medicine Division of Continuing Professional Development (License Number 7270) is an approved continuing education provider for Social Workers through the Texas State Board of Social Worker Examiners. This activity has been approved for 1 continuing education unit.

Term of Approval

October 1, 2025 through October 31, 2027. Original release date: October 1, 2025.

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.